DOST approves clinical trials for 'lagundi' as therapeutic supplement for COVID-19

DOST approves clinical trials for 'lagundi' as therapeutic supplement for COVID-19

書目詳細資料
發表在:Manila Bulletin Vol. 571, no. 19 (19 Jul. 2020), 5
主要作者: Nazario, Dhel
格式: Article
出版: 2020
主題:
Lagundi > Therapeutic use
Clinical trials
Philippines. Department of Science and Technology. Philippine Council for Health Research and Development